Бастиан Блоэм - Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний
- Название:Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний
- Автор:
- Жанр:
- Издательство:Эксмо
- Год:2021
- Город:Москва
- ISBN:978-5-04-155994-6
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Бастиан Блоэм - Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний краткое содержание
Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
43. Там же.
44. Там же.; Lung cancer. Wikipedia. https://en.wikipedia.org/wiki/Lung_ cancer. Accessed February 15, 2019.
45. Keating C. Smoking Kills: The Revolutionary Life of Richard Doll. Oxford: Signal Books; 2009.
46. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. BMJ . 1956;2(5001):1071–1081.
47. Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tobacco Control . 2012;21(2):87–91.
48. Flanders WD, Lally CA, Zhu B-P, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption. Cancer Research. 2003;63(19):6556–6562.
49. Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer – relative risk estimates for the major histological types from a pooled analysis of case-control studies. International Journal of Cancer. 2012;131(5):1210–1219.
50. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953; Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson’s disease: a meta-analysis. Archives of Gerontology and Geriatrics. 2015;61(3):510–516.
51. Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Translational Neurodegeneration. 2017;6:18; Maggio R, Riva M, Vaglini F, et al. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. Journal of Neurochemistry. 1998;71(6):2439–2446; Allam MF, Serrano del Castillo A, Fernandez-Crehuet Navajas R. Smoking and Parkinson’s disease: explanatory hypothesis. International Journal of Neuroscience. 2002; 112(7):851–854; Miksys S, Tyndale RF. Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease. Journal of Neural Transmission, Supplement. 2006(70):177–180.
52. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLOS ONE. 2013;8(3):e59260; Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262.
53. Pagliuca G, Rosato C, Martellucci S, et al. Cytologic and functional alterations of nasal mucosa in smokers: temporary or permanent damage? Otolaryngology – Head and Neck Surgery. 2015;152(4):740–745; Utiyama DMO, Yoshida CT, Goto DM, et al. The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clinics. 2016;71(6):344–350; Martin EM, Clapp PW, Rebuli ME, et al. E-cigarette use results in suppression of immune and inflammatoryresponse genes in nasal epithelial cells similar to cigarette smoke. American Journal of Physiology – Lung Cellular and Molecular Physiology. 2016;311(1):L135-L144.
54. Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262; Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson’s disease. Movement Disorders. 2014;29(8):976–979.
55. Hopfner F, Kunstner A, Muller SH, et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Research. 2017;1667:41–45; Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: a review. Annals of Neurology. 2017;81(3):369–382; Hasegawa S, Goto S, Tsuji H, et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease. PLOS ONE. 2015;10(11):e0142164; Keshavarzian A, Green SJ, Engen PA, et al. Colonic bacterial composition in Parkinson’s disease. Movement Disorders. 2015;30(10):1351–1360.
56. Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262.
57. Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell. 2016;167(6):1469–1480.e12.
58. Там же.
59. Health risks of smoking tobacco. American Cancer Society. Cancer A-Z. www.cancer.org/ cancer/cancer-causes/tobacco-and-cancer/health-risks-of-smoking-tobacco.html. Accessed February 15, 2019.
60. Dorsey ER, Sherer T, Okun M, Bloem BR. The emerging evidence of the Parkinson pandemic. Journal of Parkinson’s Disease. 2018;8(Suppl 1):S3-S8.
61. Morris AD, Rose FC. James Parkinson: His Life and Times. Birkhauser; 1989.
62. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Quarterly. 2005;83(4):731–757.
63. Fauci AS, Morens DM, Folkers GK. What is a Pandemic? Journal of Infectious Diseases. 2009;200(7):1018–1021.
64. Black death. Wikipedia. https://en.wikipedia.org/wiki/Black_Death. Accessed February 15, 2019.
65. Barry JM. The Great Influenza: The Story of the Deadliest Pandemic in History. Rev. ed: Penguin Books; 2005.
66. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2095–2128.
67. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Quarterly. 2005;83(4):731–757.
68. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Quarterly . 1986;64(3):355–391.
69. Allen L. Are we facing a noncommunicable disease pandemic? Journal of Epidemiology and Global Health. 2017;7(1):5–9.
70. Fauci AS, Morens DM, Folkers GK. What is a Pandemic? Journal of Infectious Diseases. 2009;200(7):1018–1021.
71. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953.
72. Там же.
73. Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74(2):163–169.
74. Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: Final Data for 2014. US Department of Health and Human Services; June 30, 2016.
75. FAOSTAT: pesticides. Food and Agriculture Organization of the United Nations. www.fao.org/faostat/en/#data/EP/visualize. Accessed February 15, 2019; Friesen MC, Locke SJ, Chen Y-C, et al. Historical occupational trichloroethylene air concentrations based on inspection measurements from Shanghai, China. Annals of Occupational Hygiene . 2015;59(1):62–78; Tang Z. The characteristics of urban air pollution in China. In: Urbanization, Energy, and Air Pollution in China: The Challenges Ahead: Proceedings of a Symposium . National Academies Press; 2004:47–54.
76. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953.
77. Parashos SA, Maraganore DM, O’Brien PC, Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clinic Proceedings. 2002;77(9):918–925; Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74(2):163–169; Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson’s disease: a populationbased, prospective study. Journal of the American Geriatrics Society . 2000;48(8):938–942; Dorsey ER, Deuel LM, Voss TS, et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson’s disease. Movement Disorders. 2010;25(11):1652–1659.
78. Hinz M, Stein A, Cole T. The Parkinson’s disease death rate: carbidopa and vitamin B6. Journal of Clinical Pharmacology. 2014;6:161–169.
Глава 3: Преодолевая равнодушие
1. Furnish D. To those who stood against AIDS apathy: thank you. Huffington Post. November 8, 2013.
2. Litsky F, Weber B. Roger Bannister, first athlete to break the 4-minute mile, is dead at 88. New York Times. March 5, 2018; Ingle S. Interview: Roger Bannister turns clock back 60 years and still feels the thrill. The Running Blog. Guardian. May 5, 2014; Crouch I. Roger Bannister’s solitary pursuit of the four-minute mile. New Yorker. March 5, 2018.
3. Guinness World Records. First sub-four minute mile – Sir Roger Bannister – Guinness World Records 60th anniversary [видео]. YouTube. December 8, 2014. www.youtube.com/watch?v=ku1vdrWQuJY.
4. Там же.
5. Bannister R. Roger Bannister: “The day I broke the four-minute mile.” Daily Telegraph. March 30, 2014.
6. Litsky F, Weber B. Roger Bannister, first athlete to break the 4-minute mile, is dead at 88. New York Times. March 5, 2018; Roger Bannister. In: Dana R. Barnes, ed. Notable Sports Figures. Vol 1. Gale Group; 2004:86.
7. Limb M. Roger Gilbert Bannister: innovative neurologist and the first athlete to run a mile in less than four minutes. BMJ. 2018;361:k1589.
8. Litsky F, Weber B. Roger Bannister, first athlete to break the 4-minute mile, is dead at 88. New York Times. March 5, 2018.
9. Oshinsky DM. Polio: An American Story. Oxford University Press; 2006.
10. Там же.
11. Там же.
12. Goldman AS, Schmalstieg EJ, Freeman DH, Goldman DA, Schmalstieg FC. What was the cause of Franklin Delano Roosevelt’s paralytic illness? Journal of Medical Biography. 2003;11(4):232–240.
13. Oshinsky DM. Polio: An American Story . Oxford University Press; 2006.
14. Там же.
15. Там же.
16. Там же.
17. Там же.
18. Там же.
19. Там же.
20. Там же.
21. Admin. History of health care. What If America Had a Healthcare System That Worked? December 20, 2009. http://whatifpost.com/ health-care-resources/history-of-health-care.
22. Oshinsky DM. Polio: An American Story. Oxford University Press; 2006.
23. Moore W. Paralysed with fear: the story of polio by Gareth Williams– review. Guardian. July 17, 2013;Culture.
24. Poliomyelitis. Wikipedia. https://en.wikipedia.org/wiki/Poliomyelitis. Accessed October 15, 2018.
25. Resnick B. What America looked like: polio children paralyzed in iron lungs. Atlantic. January 10, 2012.
26. Press TA. Woman dies after life spent in iron lung. CNN. 2008. https:// web.archive.org/ web/20081022162511/http:/www.cnn.com/2008/ US/05/28/iron.lung.death.ap/index.html. Updated May 28. Accessed March 4, 2019.
Читать дальшеИнтервал:
Закладка:
